Skip to search.
 FTSE 100 Down 0.33%

More On QLTI

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Novelion Therapeutics Inc. (QLTI)

-NasdaqGS
1.95 0.00(0.00%) 29 Nov 21:00
Prev Close:1.95
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:2.73
Beta:-0.132204
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:1.22 - 3.00
Volume:0
Avg Vol (3m):144,403
Market Cap:106.11m
P/E (ttm):N/A
EPS (ttm):-0.69
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for QLTI at this time.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:28-Jun-13

Analysts

Annual EPS Est (Dec-16) :-0.73
Quarterly EPS Est (Dec-16) :-0.11
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):0.13

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novelion Therapeutics Inc., a biopharmaceutical company, develops a portfolio of therapies for individuals living with rare diseases. Its product portfolio includes MYALEPT for the treatment of generalized lipodystrophy; JUXTAPID for treating homo... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback